advertisement
Abstract #5700 Published in IGR 2-1
Pharmacotherapy of congenital glaucoma in young children
Koraszewska-Matuszewska BKlinika Oczna 1999; 101:393-396
The aim of congenital glaucoma treatment is to preserve visual function in the child's eyes. There are three forms of congenital glaucoma: primary congenital glaucoma in infants, children and the young, glaucoma in dysgenesis of the anterior segment of the eyeball, and glaucoma during congenital systemic diseases. Pharmacotherapy is indicated during preparation for surgical treatment, as an adjunct following surgical procedures and to protect retinal and optic nerve function. Carbonic anhydrase inhibitors, hyperosmotic agents, sympathomimetic drugs, parasympathomimetic drugs, and prostaglandins may be used. Dopamine antagonists, calcium channel blockers, and serotonine antagonists are indicated to protect retinal cells and optic nerve function. The most widely used are carbonic anhydrase inhibitors and beta-blockers: betaxolol. Antiglaucoma drugs have proven to be efficacious in treating children with congenital glaucoma, but they have several serious side-effects. Therefore, pharmacotherapy can be used only periodically. The main treatment of congenital glaucoma is surgical treatment. LA: Polish
Dr. B. Koraszewska-Matuszewska, ul. Zwirki i Wigury 15, 40-063 Katowice, Poland
Classification:
9.1 Developmental glaucomas (Part of: 9 Clinical forms of glaucomas)
11.1 General management, indication (Part of: 11 Medical treatment)
